{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T09:53:46Z","timestamp":1776938026359,"version":"3.51.4"},"reference-count":27,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2025,5,26]]},"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1136\/ejhpharm-2025-004523","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T02:50:16Z","timestamp":1749610216000},"page":"260-265","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of potential particulate contamination in intravenous solutions in an adult intensive care unit: a targeted correlation analysis"],"prefix":"10.1136","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4321-1553","authenticated-orcid":false,"given":"Yvonne","family":"Remane","sequence":"first","affiliation":[{"name":"Drug Safety Center, Leipzig University and Leipzig University Medical Center, Leipzig, Germany"},{"name":"Pharmacy, Leipzig University Medical Center, Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annett","family":"Frisch","sequence":"additional","affiliation":[{"name":"Pharmacy, Leipzig University Medical Center, Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Krainz","sequence":"additional","affiliation":[{"name":"Pharmacy, Leipzig University Medical Center, Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Vogel","sequence":"additional","affiliation":[{"name":"Pharmacy, Leipzig University Medical Center, Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Ranft","sequence":"additional","affiliation":[{"name":"Pharmacy, Leipzig University Medical Center, Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Borella","sequence":"additional","affiliation":[{"name":"Pharmacy, Leipzig University Medical Center, Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent-Christoph","family":"Klaus","sequence":"additional","affiliation":[{"name":"Pharmacy, Leipzig University Medical Center, Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirak","family":"Petros","sequence":"additional","affiliation":[{"name":"Interdisciplinary Medical Intensive Care, Leipzig University Medical Center, Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thilo","family":"Bertsche","sequence":"additional","affiliation":[{"name":"Drug Safety Center, Leipzig University and Leipzig University Medical Center, Leipzig, Germany"},{"name":"Clinical Pharmacy, Institute of Pharmacy, Medical Faculty, Leipzig University, Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"2026042302151376000_33.3.260.1","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1248\/bpb.29.2321","article-title":"Particulate and microbial contamination in in-use admixed intravenous infusions","volume":"29","author":"Yorioka","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"2026042302151376000_33.3.260.2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.2042-7158.1987.tb06260.x","article-title":"Particulate contaminants of intravenous medications and infusions","volume":"39","author":"Backhouse","year":"1987","journal-title":"J Pharm Pharmacol"},{"key":"2026042302151376000_33.3.260.3","doi-asserted-by":"crossref","DOI":"10.1186\/s40635-018-0205-2","article-title":"Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study","volume":"6","author":"Benlabed","year":"2018","journal-title":"Intensive Care Med Exp"},{"key":"2026042302151376000_33.3.260.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-012-2539-7"},{"key":"2026042302151376000_33.3.260.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200201-027OC"},{"key":"2026042302151376000_33.3.260.6","doi-asserted-by":"publisher","DOI":"10.1136\/adc.67.12.1475"},{"key":"2026042302151376000_33.3.260.7","unstructured":"Diamond M , Peniston HL , Sanghavi DK , et al . Acute Respiratory Distress Syndrome. Treasure Island (FL): StatPearls Publishing, 2024."},{"key":"2026042302151376000_33.3.260.8","first-page":"476","article-title":"Quantitative Analysen \u00fcber den Partikelgehalt von Infusionsl\u00f6sungen, -zubeh\u00f6r und Medikamenten","volume":"26","author":"Ahnefeld","year":"1977","journal-title":"Anaesthesist"},{"key":"2026042302151376000_33.3.260.9","first-page":"617","article-title":"Particulate contamination of infusion solutions and drug additives in the framework of long-term intensive therapy. 2. An animal model","volume":"38","author":"Walpot","year":"1989","journal-title":"Anaesthesist"},{"key":"2026042302151376000_33.3.260.10","first-page":"3","article-title":"Contaminant Identification in Pharmaceutical Products","volume":"51","author":"Shearer","year":"2003","journal-title":"The Microscope"},{"key":"2026042302151376000_33.3.260.11","doi-asserted-by":"publisher","DOI":"10.5731\/pdajpst.2015.01037"},{"key":"2026042302151376000_33.3.260.12","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/jps.23217","article-title":"The potential clinical relevance of visible particles in parenteral drugs","volume":"101","author":"Doessegger","year":"2012","journal-title":"J Pharm Sci"},{"key":"2026042302151376000_33.3.260.13","unstructured":"European Directorate for the Quality of Medicines & HealthCare (EDQM) . European Pharmacopoeia. Strasbourg: Council of Europe, 2023."},{"key":"2026042302151376000_33.3.260.14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00103-016-2487-4","article-title":"Pr\u00e4vention von Infektionen, die von Gef\u00e4\u00dfkathetern ausgehen","volume":"60","year":"2017","journal-title":"Bundesgesundheitsbl"},{"key":"2026042302151376000_33.3.260.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-010-1775-y"},{"key":"2026042302151376000_33.3.260.16","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-019-2618-z","article-title":"In-line filtration of intravenous infusion may reduce organ dysfunction of adult critical patients","volume":"23","author":"Schmitt","year":"2019","journal-title":"Crit Care"},{"key":"2026042302151376000_33.3.260.17","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-015-0080-x","article-title":"Influence of in-line microfilters on systemic inflammation in adult critically ill patients: a prospective, randomized, controlled open-label trial","volume":"5","author":"Gradwohl-Matis","year":"2015","journal-title":"Ann Intensive Care"},{"key":"2026042302151376000_33.3.260.18","doi-asserted-by":"crossref","first-page":"7714","DOI":"10.1038\/s41598-018-25602-6","article-title":"Effectiveness of in-Line Filters to Completely Remove Particulate Contamination During a Pediatric Multidrug Infusion Protocol","volume":"8","author":"Perez","year":"2018","journal-title":"Sci Rep"},{"key":"2026042302151376000_33.3.260.19","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082069","article-title":"Evaluation of Strategies for Reducing Vancomycin-Piperacillin\/Tazobactam Incompatibility","volume":"15","author":"Martin Mena","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026042302151376000_33.3.260.20","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1016\/j.xphs.2021.06.022","article-title":"Assessing the Utility of In-Line Intravenous Infusion Filters","volume":"110","author":"Ayres","year":"2021","journal-title":"J Pharm Sci"},{"key":"2026042302151376000_33.3.260.21","doi-asserted-by":"crossref","DOI":"10.1213\/01.ane.0000260552.76585.53","article-title":"How to enter a medication vial without coring","volume":"104","author":"Roth","year":"2007","journal-title":"Anesth Analg"},{"key":"2026042302151376000_33.3.260.22","doi-asserted-by":"publisher","DOI":"10.5731\/pdajpst.2015.006189"},{"key":"2026042302151376000_33.3.260.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(01)00708-0"},{"key":"2026042302151376000_33.3.260.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-59245-7","article-title":"Spallation and particles infusion into the extracorporeal circuit during CRRT: a preventable phenomenon","volume":"14","author":"Ruffa","year":"2024","journal-title":"Sci Rep"},{"key":"2026042302151376000_33.3.260.25","doi-asserted-by":"crossref","first-page":"123091","DOI":"10.1016\/j.ijpharm.2023.123091","article-title":"Comparative study between a gravity-based and peristaltic pump for intravenous infusion with respect to the generation of proteinaceous microparticles","volume":"642","author":"Hada","year":"2023","journal-title":"Int J Pharm"},{"key":"2026042302151376000_33.3.260.26","doi-asserted-by":"crossref","first-page":"101473","DOI":"10.1016\/j.jddst.2019.101473","article-title":"Dynamic particle count during drug infusion: Method characterization and analysis of factors influencing results","volume":"55","author":"Martin Mena","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"2026042302151376000_33.3.260.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(01)00536-6"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2025-004523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T09:16:21Z","timestamp":1776935781000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2025-004523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4,23]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/ejhpharm-2025-004523"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2025-004523","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]}}}